Sijibio Secures Filler Export Deal Worth 10 Billion KRW in Latin America

Sijibio announced on the 26th that it participated in the 'World Aesthetic Anti-Aging Medicine Congress (AMWC) Latin America 2023' held in Medellin, Colombia from the 19th to the 21st, and signed a contract to supply collagen regeneration filler 'Facstem' and hyaluronic acid (HA) filler 'Eilin' to Colombia and Venezuela worth 10 billion KRW over three years.

Dr. Gustavo Madrid is demonstrating a live procedure using CGBio's collagen regeneration filler 'Facstem'.
[Photo by CGBio]

AMWC is an academic conference in the field of plastic surgery and aesthetic clinics. At this Latin America conference, lectures and workshops were conducted for about 1,000 medical professionals and industry workers from South America, and more than 70 companies participated in the exhibition to introduce the latest anti-aging technologies and products. Sijibio also opened an independent booth and showcased its main products Facstem and Eilin, as well as another HA filler 'Gisellinew' and lifting thread 'Exoft'.

Through this conference, Sijibio successfully signed a supply contract for Facstem and Eilin worth approximately 10 billion KRW over three years for Colombia and Venezuela. In addition, meetings were held with distributors and multiple key opinion leaders (KOLs) in Latin America to confirm the possibility of full-scale business expansion in the Latin American market, including Colombia.

Additionally, Dr. Gustavo Madrid from Colombia gave a lecture on 'Clinical advanced techniques & practical considerations in the use of Calcium Hydroxyapatite for facial rejuvenation,' capturing the attention of attendees. In his lecture, Dr. Madrid introduced the excellence of Facstem, which applies Sijibio's proprietary hydroxyapatite processing technology, and presented various indications and procedural techniques such as mid-face lifting, jawline improvement, and lower face contour enhancement through the use of Facstem alone and in combination with HA fillers, along with live demonstrations.

Yoo Hyun-seung, CEO of Sijibio, said, “It is meaningful to introduce Sijibio’s products with proprietary technology to South American medical professionals by attending this conference,” and added, “Based on the contracts concluded at this conference, we will actively target the Latin American aesthetic plastic surgery market to expand our business.”

This content was produced with the assistance of AI translation services.